Companies / Biocryst Pharmaceuticals Inc / Activity
Activity — Biocryst Pharmaceuticals Inc
106 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Janus Henderson Group PLC 13F manager | Add | Common stock | $14.33M | +1.5M +20.31% | 8,908,506 3.49% of shares | medium |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Add | Common stock | $17.87M | +1.9M +41.58% | 6,392,628 2.50% of shares | medium |
| Q1 2026 as of | Baker Bros. Advisors LP 13F manager | Exit | Common stock | $-22.02M | -2.8M -100.00% | 0 | medium |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $27.55M | +2.8M +13.03% | 23,893,036 9.35% of shares | medium |
| Q1 2026 as of | Perceptive Advisors LLC 13F manager | Add | Common stock | $40.66M | +4.3M +135.07% | 7,434,033 2.91% of shares | medium |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common stock | $41.18M | +4.1M +37.19% | 15,191,098 5.94% of shares | medium |